Groups | rs2302254 C/T | ||||||
---|---|---|---|---|---|---|---|
CC | CT | TT | P value | C | T | P value | |
Control N = 48 | 26 (54.2%) | 20 (41.7%) | 2 (4.2%) | 0.587 | 72 (75%) | 24 (25%) | 0.943 |
Patients N = 136 | 77 (56.6%) | 49 (36.0%) | 10 (7.4%) |  | 203 (74.6%) | 69 (25.4%) |  |
Groups | rs16949649 T/C | ||||||
---|---|---|---|---|---|---|---|
CC | TC | TT | P value | C | T | P value | |
Control N = 48 | 13 (27.1%) | 18 (37.5%) | 17 (35.4%) | 0.251 | 44 (45.8%) | 52 (54.2%) | 0.343 |
Patients N = 136 | 33 (24.3%) | 74 (54.4%) | 29 (21.3%) |  | 140 (51.5%) | 132 (48%) |  |